Glenmark Life Sciences Ltd 24 Jan 2024 12:00 AM
Glenmark Life Sciences standalone net profit rises 13.13% in the December 2023 quarter,
Net profit of Glenmark Life Sciences rose 13.13% to Rs 118.77 crore in the quarter ended December 2023 as against Rs 104.99 crore during the previous quarter ended December 2022. Sales rose 5.93% to Rs 572.80 crore in the quarter ended December 2023 as against Rs 540.73 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales572.80540.73 6 OPM %30.1326.90 - PBDT173.87151.90 14 PBT160.69141.14 14 NP118.77104.99 13 Powered by Capital Market - Live News
Glenmark Life Sciences Ltd 19 Jan 2024 12:00 AM
Glenmark Life Sciences signs Master Supply Agreement with Japanese innovator pharma company,
Glenmark Life Sciences (GLS) announced the signing of a Master Supply Agreement (MSA) with a Japanese innovator pharmaceutical company with global presence in Europe, United States and Asia. Under the aegis of the Master Supply Agreement, Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator. Glenmark Life Sciences will leverage its expertise in API manufacturing to support the global pharmaceutical innovator`s initiative in the field of urinary anti-spasmodic therapeutics. As part of this collaboration, product portfolios of various affiliates of the global innovator may also be added in the future. The API for the finished formulation will be supplied to all major regulated markets such as United States, Europe and Japan. The estimated commercial value of this project is expected to be around $5million. Powered by Capital Market - Live News
Glenmark Life Sciences Ltd 16 Jan 2024 12:00 AM
Glenmark Life Sciences schedules board meeting,
Glenmark Life Sciences will hold a meeting of the Board of Directors of the Company on 23 January 2024.Powered by Capital Market - Live News
Glenmark Life Sciences Ltd 20 Oct 2023 12:00 AM
Glenmark Life Sciences standalone net profit rises 11.10% in the September 2023 quarter,
Net profit of Glenmark Life Sciences rose 11.10% to Rs 118.74 crore in the quarter ended September 2023 as against Rs 106.88 crore during the previous quarter ended September 2022. Sales rose 16.90% to Rs 595.36 crore in the quarter ended September 2023 as against Rs 509.30 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales595.36509.30 17 OPM %28.0728.20 - PBDT172.06153.53 12 PBT158.93143.59 11 NP118.74106.88 11 Powered by Capital Market - Live News
Glenmark Life Sciences Ltd 14 Oct 2023 12:00 AM
Glenmark Life Sciences announces board meeting date,
Glenmark Life Sciences will hold a meeting of the Board of Directors of the Company on 20 October 2023.Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now